Clinical Trial Update: The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

View source ↗

Summary

A University of Virginia clinical trial is investigating quantitative CT and radiomic biomarkers to advance precision medicine in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: University of Virginia | Conditions: Idiopathic Pulmonary Fibrosis | Status: RECRUITING